|
FDA providing $2 million in new grants for natural history studies in rare diseases
|
29 February 2016 |
|
FDA seeks $5.1 billion total for FY 2017
|
10 February 2016 |
|
Califf, FDA top officials call for sweeping review of agency opioids policies
|
04 February 2016 |
|
FDA approves first drug to show survival benefit in liposarcoma
|
28 January 2016 |
|
FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients
|
08 December 2015 |
|
FDA approves Opdivo to treat advanced form of kidney cancer
|
24 November 2015 |
|
FDA approves new treatment for HIV
|
06 November 2015 |
|
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa
|
19 October 2015 |
|
FDA approves new injectable drug to treat schizophrenia
|
09 October 2015 |
|
FDA approves Keytruda for advanced non-small cell lung cancer
|
05 October 2015 |
|
FDA approves first treatment for sexual desire disorder
|
19 August 2015 |
|
FDA takes action to protect consumers from potentially dangerous counterfeit medicines and devices sold online
|
03 July 2015 |
|
FDA approves anti-clotting drug Savaysa
|
15 January 2015 |
|
FDA warns consumers about fraudulent Ebola treatment products
|
14 August 2014 |
|
FDA issues guidance to support the responsible development of nanotechnology products
|
25 June 2014 |
|
FDA launches openFDA to provide easy access to valuable FDA public data
|
13 June 2014 |
|
FDA requires removal of certain restrictions on the diabetes drug Avandia
|
26 November 2013 |
|
FDA approves new drug to treat HIV infection
|
15 August 2013 |
|
FDA alerts companies to stop illegal sale of treatments for diabetes
|
23 July 2013 |
|
FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies
|
27 June 2013 |